Bart van der Sanden

Bart van der Sanden

Auto-generated profile, based on publicly available information

Bart van der Sanden

Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2022 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
BSBart P. G. H. van der Sanden
Bart P. G. H. van der Sanden
GSGaby Schobers
Gaby Schobers
JGJordi Corominas Galbany
Jordi Corominas Galbany
DKDavid A. Koolen
David A. Koolen
MSMargje Sinnema
Margje Sinnema
LVLisenka E. L. M. Vissers
Lisenka E. L. M. Vissers
Genome sequencing (GS) can identify novel diagnoses for patients who remain undiagnosed after routine diagnostic procedures. We tested whether GS is a better first-tier genetic diagnostic test than current standard of care (SOC) by assessing the technical and clinical validity of GS for patients with neurodevelopmental disorders (NDD). We performed both GS and exome sequencing in 150 consecutive NDD patient-parent trios. The primary outcome was diagnostic yield, calculated from disease-causing variants affecting exonic sequence of known NDD genes. GS (30%,n = 45) and SOC (28.7%,n = 43) had similar diagnostic yield. All 43 conclusive diagnoses obtained with SOC testing were also identified by GS. SOC, however, required integration of multiple test results to obtain these diagnoses. GS yielded two more conclusive diagnoses, and four more possible diagnoses than ES-based SOC (35 vs. 31). Interestingly, these six variants detected only by GS were copy number variants (CNVs). Our data demonstrate the technical and clinical validity of GS to serve as routine first-tier genetic test for patients with NDD. Although the additional diagnostic yield from GS is limited, GS comprehensively identified all variants in a single experiment, suggesting that GS constitutes a more efficient genetic diagnostic workflow.

8 May 2023 in Genome Medicine
Verified
Journal Article
Open access
PDF file
EKErdi Kucuk
Erdi Kucuk
BSBart P. G. H. van der Sanden
Bart P. G. H. van der Sanden
LOLuke O’gorman
Luke O’gorman
MKMichael Kwint
Michael Kwint
RDRonny Derks
Ronny Derks
CGChristian Gilissen
Christian Gilissen
Background: Long-read sequencing (LRS) techniques have been very successful in identifying structural variants (SVs). However, the high error rate of LRS made the detection of small variants (substitutions and short indels < 20 bp) more challenging. The introduction of PacBio HiFi sequencing makes LRS also suited for detecting small variation. Here we evaluate the ability of HiFi reads to detect de novo mutations (DNMs) of all types, which are technically challenging variant types and a major cause of sporadic, severe, early-onset disease. Methods: We sequenced the genomes of eight parent–child trios using high coverage PacBio HiFi LRS (~ 30-fold coverage) and Illumina short-read sequencing (SRS) (~ 50-fold coverage). De novo substitutions, small indels, short tandem repeats (STRs) and SVs were called in both datasets and compared to each other to assess the accuracy of HiFi LRS. In addition, we determined the parent-of-origin of the small DNMs using phasing. Results: We identified a total of 672 and 859 de novo substitutions/indels, 28 and 126 de novo STRs, and 24 and 1 de novo SVs in LRS and SRS respectively. For the small variants, there was a 92 and 85% concordance between the platforms. For the STRs and SVs, the concordance was 3.6 and 0.8%, and 4 and 100% respectively. We successfully validated 27/54 LRS-unique small variants, of which 11 (41%) were confirmed as true de novo events. For the SRS-unique small variants, we validated 42/133 DNMs and 8 (19%) were confirmed as true de novo event. Validation of 18 LRS-unique de novo STR calls confirmed none of the repeat expansions as true DNM. Confirmation of the 23 LRS-unique SVs was possible for 19 candidate SVs of which 10 (52.6%) were true de novo events. Furthermore, we were able to assign 96% of DNMs to their parental allele with LRS data, as opposed to just 20% with SRS data. Conclusions: HiFi LRS can now produce the most comprehensive variant dataset obtainable by a single technology in a single laboratory, allowing accurate calling of substitutions, indels, STRs and SVs. The accuracy even allows sensitive calling of DNMs on all variant levels, and also allows for phasing, which helps to distinguish true positive from false positive DNMs.

30 November 2020 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
MPMarc Pauper
Marc Pauper
EKErdi Kucuk
Erdi Kucuk
AWAaron M. Wenger
Aaron M. Wenger
SCShreyasee Chakraborty
Shreyasee Chakraborty
PBPrimo Baybayan
Primo Baybayan
CGChristian Gilissen
Christian Gilissen
Long-read sequencing (LRS) has the potential to comprehensively identify all medically relevant genome variation, including variation commonly missed by short-read sequencing (SRS) approaches. To determine this potential, we performed LRS around 15×–40× genome coverage using the Pacific Biosciences Sequel I System for five trios. The respective probands were diagnosed with intellectual disability (ID) whose etiology remained unresolved after SRS exomes and genomes. Systematic assessment of LRS coverage showed that ~35 Mb of the human reference genome was only accessible by LRS and not SRS. Genome-wide structural variant (SV) calling yielded on average 28,292 SV calls per individual, totaling 12.9 Mb of sequence. Trio-based analyses which allowed to study segregation, showed concordance for up to 95% of these SV calls across the genome, and 80% of the LRS SV calls were not identified by SRS. De novo mutation analysis did not identify any de novo SVs, confirming that these are rare events. Because of high sequence coverage, we were also able to call single nucleotide substitutions. On average, we identified 3 million substitutions per genome, with a Mendelian inheritance concordance of up to 97%. Of these, ~100,000 were located in the ~35 Mb of the genome that was only captured by LRS. Moreover, these variants affected the coding sequence of 64 genes, including 32 known Mendelian disease genes. Our data show the potential added value of LRS compared to SRS for identifying medically relevant genome variation.

20 March 2025 in Genome Research
Verified
Journal Article
Open access
PDF file
BSBart van der Sanden
Bart van der Sanden
KNKornelia Neveling
Kornelia Neveling
SSSyukri Shukor
Syukri Shukor
MGMichael D. Gallagher
Michael D. Gallagher
JLJoyce Lee
Joyce Lee
AHAlex Hoischen
Alex Hoischen
Short tandem repeats (STRs) are common variations in human genomes that frequently expand or contract, causing genetic disorders, mainly when expanded. Traditional diagnostic methods for identifying these expansions, such as repeat-primed PCR and Southern blotting, are often labor-intensive, locus-specific, and are unable to precisely determine long repeat expansions. Sequencing-based methods, although capable of genome-wide detection, are limited by inaccuracy (short-read technologies) and high associated costs (long-read technologies). This study evaluated optical genome mapping (OGM) as an efficient, accurate approach for measuring STR lengths and assessing somatic stability in 85 samples with known pathogenic repeat expansions in DMPK , CNBP , and RFC1 , causing myotonic dystrophy types 1 and 2 and cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS), respectively. Three workflows—manual de novo assembly, local guided assembly (local-GA), and a molecule distance script—were applied, of which the latter two were developed as part of this study to assess the repeat sizes and somatic repeat stability. OGM successfully identified 84/85 (98.8%) of the pathogenic expansions, distinguishing between wild-type and expanded alleles or between two expanded alleles in recessive cases, with greater accuracy than standard of care (SOC) for long repeats and no apparent upper size limit. Notably, OGM detected somatic instability in a subset of DMPK , CNBP , and RFC1 samples. These findings suggest OGM could advance diagnostic accuracy for large repeat expansions, providing a more comprehensive genome-wide assay for repeat expansion disorders by measuring exact repeat lengths and somatic instability across multiple loci simultaneously.

5 July 2024 in Current Protocols
Verified
Journal Article
Open access
BSBart van der Sanden
Bart van der Sanden
KNKornelia Neveling
Kornelia Neveling
APAndy Wing Chun Pang
Andy Wing Chun Pang
SSSyukri Shukor
Syukri Shukor
MGMichael D. Gallagher
Michael D. Gallagher
AHAlex Hoischen
Alex Hoischen
Short tandem repeat (STR) expansions are associated with more than 60 genetic disorders. The size and stability of these expansions correlate with the severity and age of onset of the disease. Therefore, being able to accurately detect the absolute length of STRs is important. Current diagnostic assays include laborious lab experiments, including repeat‐primed PCR and Southern blotting, that still cannot precisely determine the exact length of very long repeat expansions. Optical genome mapping (OGM) is a cost‐effective and easy‐to‐use alternative to traditional cytogenetic techniques and allows the comprehensive detection of chromosomal aberrations and structural variants >500 bp in length, including insertions, deletions, duplications, inversions, translocations, and copy number variants. Here, we provide methodological guidance for preparing samples and performing OGM as well as running the analysis pipelines and using the specific repeat expansion workflows to determine the exact repeat length of repeat expansions expanded beyond 500 bp. Together these protocols provide all details needed to analyze the length and stability of any repeat expansion with an expected repeat size difference from the expected wild‐type allele of >500 bp. © 2024 The Authors. Current Protocols published by Wiley Periodicals LLC.Basic Protocol 1: Genomic ultra‐high‐molecular‐weight DNA isolation, labeling, and stainingBasic Protocol 2: Data generation and genome mapping using the Bionano Saphyr® SystemBasic Protocol 3: Manual De Novo Assembly workflowBasic Protocol 4: Local guided assembly workflowBasic Protocol 5: EnFocus Fragile X workflowBasic Protocol 6: Molecule distance script workflow

9 September 2025 in Nature Genetics
Verified
Journal Article
Closed access
VYVicente A Yépez
Vicente A Yépez
GDGerman Demidov
German Demidov
KEKornelia Ellwanger
Kornelia Ellwanger
SLSteven Laurie
Steven Laurie
RLRebeka Luknárová
Rebeka Luknárová
HGHolm Graessner
Holm Graessner